46 research outputs found
Notalgia paresthetica
Notalgia paresthetica is a common, although under-recognized condition characterized by localized chronic pruritus in the upper back, most often affecting middle-aged women. Apart from pruritus, patients may present with a burning or cold sensation, tingling, surface numbness, tenderness and foreign body sensation. Additionally, patients often present with hyperpigmented skin at the site of symptoms. The etiology of this condition is still poorly understood, although a number of hypotheses have been described. It is widely accepted that notalgia paresthetica is a sensory neuropathy caused by alteration and damage to posterior rami of thoracic spinal nerves T2 through T6. To date, no well-defined treatment has been found, although many treatment modalities have been reported with varying success, usually providing only temporary relief.Notalgia paresthetica je uÄestalo, iako slabo prepoznato stanje koje obilježava lokalizirani kroniÄni pruritus gornjeg dijela leÄa, a najÄeÅ”Äe se javlja u žena srednje životne dobi. Uz svrbež u bolesnika se takoÄer može javiti osjeÄaj žarenja ili hladnoÄe, trnci, utrnulost, osjetljivost i osjeÄaj stranog tijela. Uz to, na mjestu simptoma Äesto se javlja podruÄje hiperpigmentirane kože. Iako postoji viÅ”e hipoteza, etiologija ove bolesti slabo je poznata. OpÄe je prihvaÄeno da je notalgia paresthetica senzorna neuropatija uzrokovana oÅ”teÄenjem stražnjih ogranaka torakalnih kralježniÄnih živaca od T2 do T6. UnatoÄ mnogim razliÄitim terapijskim metodama koje su bile promjenjivoga uspjeha i najÄeÅ”Äe pružale privremeno olakÅ”anje, do danas nema uspjeÅ”noga lijeÄenja ove bolesti
NeobiÄno mjesto presadnice papilarnog karcinoma Å”titnjaÄe u nadbubrežnu žlijezdu: prikaz sluÄaja
Papillary thyroid carcinoma (PTC) is considered one of the most favorable tumors, indolent, with rare distant dissemination. Lungs and bones are the most common metastatic sites. Unusual sites of PTC distant metastases are extremely rare. Brain, liver, skin, kidney, pancreas, and adrenal gland PTC metastases have been sporadically reported in the literature. An 86-year-old female patient underwent total thyroidectomy and neck dissection due to PTC. Postoperative whole body iodine-131 scintigraphy with I-131 SPECT/CT of the abdomen revealed radioiodne avid left adrenal gland metastasis together with high postoperative serum thyroglobulin (Tg) value of more than 5000 Āµg/L and high serum Tg antibodies. Considering the above-mentioned findings, patientās age and multiple comorbidities, radioiodine therapy was applied. PTC metastases to the adrenal gland are extremely rare, and to our knowledge, only nine cases have been reported in the literature. This case report complements rare examples of unusual PTC metastases.Papilarni karcinom Å”titnjaÄe svrstava se u maligne tumore s najpovoljnijom prognozom, polaganog je rasta, a presadnice na udaljenim mjestima su rijetke. NajÄeÅ”Äa mjesta udaljene diseminacije papilarnog karcinoma Å”titnjaÄe su pluÄa i kosti. Rijetka mjesta udaljene diseminacije opisana u literaturi su mozak, jetra, koža, guÅ”teraÄa i nadbubrežna žlijezda. Bolesnica u dobi od 86 godina operirana je zbog papilarnog karcinoma Å”titnjaÄe. Nakon operativnog odstranjenja Å”titnjaÄe s tumorom i disekcije vrata uÄinjena je poslijeoperacijska onkoloÅ”ka obrada ukljuÄujuÄi scintigrafiju cijelog tijela jodom-131 uz SPECT/CT abdomena. U podruÄju lijeve nadbubrežne žlijezde zabilježena je intenzivna nakupina joda-131 koja je odgova-rala presadnici papilarnog karcinoma Å”titnjaÄe. Serumska vrijednost tumorskog biljega tireoglobulina bila je izrazito poviÅ”e-na i iznosila je viÅ”e od 5000 Āµg/L uz pozitivna antitireoglobulinska protutijela. UzevÅ”i u obzir nalaze poslijeoperacijske onkoloÅ”ke obrade, dob i opÄe loÅ”e stanje bolesnice provedeno je lijeÄenje jodom-131. Presadnice papilarnog karcinoma Å”titnjaÄe u nadbubrežnu žlijezdu su iznimno rijetke i dosad je u literaturi opisano samo 9 sluÄajeva. Ovaj prikaz bolesnice upotpunjuje dosadaÅ”nje rijetke sluÄajeve neobiÄnih mjesta udaljene diseminacije papilarnog karcinoma Å”titnjaÄe
Povezanost koÅ”tane mineralne gustoÄe i sastavnica metaboliÄkog sindroma u postmenopauzalnih žena sa Å”eÄernom boleÅ”Äu tipa 2
Diabetes mellitus type 2 is associated with greater bone mineral density (BMD) due to obesity, although rapid bone loss observed over time could be explained by elevated chronic inflammation. The objective of this study was to investigate the relationship between central adiposity and hyperinsulinemia, as well as inflammation markers with vertebral and femoral BMD and bone turnover markers in postmenopausal women with type 2 diabetes. Femoral and vertebral BMD, osteocalcin, pyrilinks D, beta-CrossLaps (B-CTx), insulin, C-reactive protein (CRP), fibrinogen and plasminogen activator inhibitor-1 (PAI-1) were measured in 114 postmenopausal female patients with diabetes type 2. The patients of similar age, HbA1c levels and diabetes duration were divided into 2 groups based on their body mass index (BMI) values: lower or equal to 27 kg/m2(31 patients) and higher than 27 kg/m2(83 patients). Lower levels of osteocalcin (p=0.001), B-CTx (p=0.000007) and pyrilinks D (p=0.0365), and higher femoral BMD (p=0.00006), insulin level (p=0.0002), PAI-1 (p=0.00000) and CRP (p=0.002) were found in the overweight group. There were no significant differences in vertebral BMD and fibrinogen. Osteocalcin and B-CTx showed inverse correlation, and femoral BMD positive correlation with waist circumference, insulin level and PAI-1. This suggests that abdominal obesity and hyperinsulinemia as components of the metabolic syndrome could increase femoral BMD by lowering bone rate. In addition, the only inflammation marker linked with femoral BMD was PAI-1, which is associated with increased mineralization of cortical bone in mouse models.Å eÄerna bolest tipa 2 povezana je s veÄom koÅ”tanom mineralnom gustoÄom (bone mineral density, BMD) zbog debljine, iako se zamijeÄeni ubrzani gubitak koÅ”tane mase tijekom vremena može objasniti prisustvom kroniÄne upale. Cilj ovoga istraživanja bio je utvrditi povezanost biljega koÅ”tane pregradnje i koÅ”tane gustoÄe s centralnom debljinom, hiperinzulinemijom kao i upalnim biljezima u postmenopauzalnih žena sa Å”eÄernom boleÅ”Äu tipa 2. U 114 ispitanica izmjerena je koÅ”tana gustoÄa kralježnice i kuka, odreÄeni su osteokalcin, pirilinks D, beta-CrossLaps (B-CTx), inzulin, C-reaktivni protein (CRP), fibrinogen i inhibitor aktivatora plazminogena-1 (PAI-1). Ispitanice sliÄne dobi, podjednakog trajanja dijabetesa te HbA1c bile su podijeljene u dvije skupine prema indeksu tjelesne mase (ITM): niži ili jednaki 27 kg/m2(31 ispitanica) te veÄi od 27 kg/m2 (83 ispitanice). Niže vrijednosti osteokalcina (p=0,001), B-CTx (p=0,000007) i pirilinksa D (p=0,0365) te viÅ”e vrijednosti koÅ”ane gustoÄe kuka (p=0,00006), inzulina (p=0,0002), PAI-1 (p=0,0000) i CRP (p=0,002) utvrÄene su u skupini s prekomjernom tjelesnom težinom. Nije bilo statistiÄki znaÄajne razlike u koÅ”tanoj gustoÄi kralježnice i vrijednosti fibrinogena. Osteokalcin i B-CTx su negativno korelirali, dok je BMD kuka bio u pozitivnoj korealciji s opsegom struka, inzulinom i PAI-1. Ovi rezultati upuÄuju na to da sastavnice metaboliÄkog sindroma, centralna debljina i hiperinzulinemija utjeÄu na poveÄanje koÅ”tane gustoÄe kuka inhibirajuÄi koÅ”tanu pregradnju. Jedini upalni biljeg povezan s BMD kuka bio je PAI-1 koji poveÄava mineralizaciju kortikalne kosti na miÅ”jem modelu
Analytical evaluation of the new Seal Autoanalyzer 3 High Resolution for urinary iodine determination
Introduction: The aim of the study was to evaluate the analytical performance of the new colorimetric, automatic analyser, Seal AutoAnalyzer 3 High Resolution (Seal AA3 HR) (Seal Analytical, Wisconsin, USA) for urinary iodine measurement.
Materials and methods: This study included testing of several analytical features of the method involving: imprecision (within-run %CVr, between- run %CVb and total laboratory precision %CVl), measurement uncertainty, carryover, linearity and method comparison, with 70 urine samples including the measuring range (20 - 700 Ī¼g/L).
Results: Within-run, %CVb and %CVl of two control levels were 2.03% and 3.04%, 0.51% and 2.61%, and 2.09% and 4.01%, respectively. Carryover effect was less than 1%. The linearity was good in the range of urinary iodine values between 60 and 500 Ī¼g/L (R2 = 0.99). Good agreement of urinary iodine values was found between manual technique and Seal AA3 HR, using Passing-Bablok regression (y = 7.84 (- 3.00 to 15.29) + 0.95 (0.90 to 1.00) x) and Blant-Altman test. Cusum test for linearity indicates that there is no significant deviation from linearity (P > 0.1).
Conclusions: The obtained results proved excellent precision, reproducibility and linearity, comparable to the already used, manual method. The New Seal AA3 HR automatic analyser is acceptable for urinary iodine measurement with very good analytical characteristics and can be used for urinary iodine epidemiological studies of the Croatian population